ArticleOpen forum infectious diseases2026

Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.

Rina Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.